126 related articles for article (PubMed ID: 8975545)
21. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.
Gudbjartsson T; Hardarson S; Petursdottir V; Thoroddsen A; Magnusson J; Einarsson GV
Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127
[TBL] [Abstract][Full Text] [Related]
22. Survival analysis of clear cell renal carcinoma according to the Charlson comorbidity index.
Santos Arrontes D; Fernández Aceñero MJ; García González JI; Martín Muñoz M; Paniagua Andrés P
J Urol; 2008 Mar; 179(3):857-61. PubMed ID: 18221956
[TBL] [Abstract][Full Text] [Related]
23. [Renal tumors smaller that 3 cm].
Vega Vega A; Gutièrrez Baños JL; Martín García B; Hernández Rodríguez R; Portillo Martín JA; Coreas Gómez MA; del Valle Schaan JI; Roca Edreira A; Villanueva Ricardo A; Gutiérrez Rodríguez R
Arch Esp Urol; 1997; 50(1):27-31. PubMed ID: 9182485
[TBL] [Abstract][Full Text] [Related]
24. [Cervical adenocarcinomas: diagnostic, prognostic and therapeutic aspects in a 49 case-control study].
Martel P; Connan L; Bonnet F; Delannes M; Farnarier J; Mihura J; El Ghaoui A
J Gynecol Obstet Biol Reprod (Paris); 2000 Feb; 29(1):48-54. PubMed ID: 10675833
[TBL] [Abstract][Full Text] [Related]
25. Renal oncocytoma: a clinicopathological analysis of 45 consecutive cases.
Gudbjartsson T; Hardarson S; Petursdottir V; Thoroddsen A; Magnusson J; Einarsson GV
BJU Int; 2005 Dec; 96(9):1275-9. PubMed ID: 16287444
[TBL] [Abstract][Full Text] [Related]
26. [Correlation between the mode of presentation of renal tumors and patient survival].
Patard JJ; Bensalah K; Vincendeau S; Rioux-Leclerq N; Guillé F; Lobel B
Prog Urol; 2003 Feb; 13(1):23-8. PubMed ID: 12703350
[TBL] [Abstract][Full Text] [Related]
27. Relationship between age at diagnosis and clinicopathologic features of renal cell carcinoma.
Verhoest G; Veillard D; Guillé F; De La Taille A; Salomon L; Abbou CC; Valéri A; Lechevallier E; Descotes JL; Lang H; Jacqmin D; Tostain J; Cindolo L; Ficarra V; Artibani W; Schips L; Zigeuner R; Mulders PF; Mejean A; Patard JJ
Eur Urol; 2007 May; 51(5):1298-304; discussion 1304-5. PubMed ID: 17174023
[TBL] [Abstract][Full Text] [Related]
28. [PCNA and Ki-67 expression in locally confined renal adenocarcinoma. Relationship with various histopathologic variables and prognostic significance].
Tejido Sánchez A; Sánchez Chapado M; Rosino Sánchez A; Passas Martínez J; Bethencourt Codes F; Ruiz Ramos P; Leiva Galvis O
Arch Esp Urol; 2002 Apr; 55(3):257-65. PubMed ID: 12068757
[TBL] [Abstract][Full Text] [Related]
29. Renal cell carcinoma in young compared to older patients: comparison of clinicopathological risk factors and survival.
Thoroddsen A; Einarsson GV; Hardarson S; Petursdottir V; Magnusson J; Jonsson E; Gudbjartsson T
Scand J Urol Nephrol; 2008; 42(2):121-5. PubMed ID: 18365922
[TBL] [Abstract][Full Text] [Related]
30. [Incidental diagnosis of renal carcinoma. Impact on prognosis and survival].
Bielsa O; Arango O; Carrasco N; Pavesi M; Nohales G; Carretero P; Gelabert-Mas A
Actas Urol Esp; 1996; 20(7):601-4. PubMed ID: 8975544
[TBL] [Abstract][Full Text] [Related]
31. Renal cell carcinoma: a clinicopathological follow-up study after radical nephrectomy.
Zubac DP; Bostad L; Gestblom C; Kihl B; Seidal T; Wentzel-Larsen T; Bakke AM
Scand J Urol Nephrol; 2007; 41(3):191-7. PubMed ID: 17469026
[TBL] [Abstract][Full Text] [Related]
32. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
[TBL] [Abstract][Full Text] [Related]
33. [Survival analysis in patients with cutaneous malignant melanoma].
Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
[TBL] [Abstract][Full Text] [Related]
34. Small renal tumors: correlation of clinical and pathological features with tumor size.
Pahernik S; Ziegler S; Roos F; Melchior SW; Thüroff JW
J Urol; 2007 Aug; 178(2):414-7; discussion 416-7. PubMed ID: 17561161
[TBL] [Abstract][Full Text] [Related]
35. [Prognosis factors in adenocarcinoma of the kidney. I. Staging, clinical and macroscopic factors of the tumor].
Gutiérrez JL; Val-Bernal JF; Portillo JA; Garijo F; Buelta L
Arch Esp Urol; 1990 Jun; 43(5):481-6. PubMed ID: 2389972
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of the involvement of the urinary collecting system in renal cell carcinoma.
Terrone C; Cracco C; Guercio S; Bollito E; Poggio M; Scoffone C; Tarabuzzi R; Porpiglia F; Scarpa RM; Fontana D; Rocca Rossetti S
Eur Urol; 2004 Oct; 46(4):472-6. PubMed ID: 15363563
[TBL] [Abstract][Full Text] [Related]
37. [Does technical progress mean clinical advantage? Analysis of clinical and histopathological parameters of renal cell carcinomas in long-term course].
Otto W; Hübner I; Burger M; Rössler W; Wieland WF; Denzinger S
Aktuelle Urol; 2009 Sep; 40(5):303-6. PubMed ID: 19670107
[TBL] [Abstract][Full Text] [Related]
38. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.
Farley JH; Hickey KW; Carlson JW; Rose GS; Kost ER; Harrison TA
Cancer; 2003 May; 97(9):2196-202. PubMed ID: 12712471
[TBL] [Abstract][Full Text] [Related]
39. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
40. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases.
Delahunt B; Eble JN; McCredie MR; Bethwaite PB; Stewart JH; Bilous AM
Hum Pathol; 2001 Jun; 32(6):590-5. PubMed ID: 11431713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
